TriangleNCT00667342 · OUTCOME
Median Duration of Neuropathic Pain Medication
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEDIAN
- Unit
- Weeks
- Interval / dispersion
- Full Range
- Time frame
- From surgery until resolution of NP symptoms, up to 6 months
What was measured
Thirty participants who underwent surgery (31 surgeries) were determined to have neuropathic pain (NP). Four participants received only opioids for NP and 26 participants (for 27 surgeries) were treated with NP specific medications including gabapentin, tricyclic antidepressant, methadone. One participant had 2 different surgical procedures and was analyzed both in the limb sparing group and in the amputation group.
Analysis population: All participants who met the criteria, had surgery, experienced neuropathic pain and were treated with NP medication.
Groups in this outcome
Amputation Group
Participants had metastatic disease at diagnosis.
Limb Sparing Group
Participants had localized disease at diagnosis. One participant had 2 surgeries.
Entire Study Group
Participants enrolled on the study who met the criteria for evaluation of neuropathic pain.
| Group | Source count |
|---|---|
| Amputation Group | 10 |
| Limb Sparing Group | 16 |
| Entire Study Group | 26 |
| Group | Source count |
|---|---|
| Amputation Group | 10 |
| Limb Sparing Group | 17 |
| Entire Study Group | 27 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Amputation Group | 6.5 | Not reported | 3.0 | 30.0 | Not reported |
| Limb Sparing Group | 7.0 | Not reported | 1.7 | 29.9 | Not reported |
| Entire Study Group | 7.0 | Not reported | 1.7 | 30.0 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 3.0
- upper Limit
- 30.0
- value
- 6.5
- group Id
- OG001
- lower Limit
- 1.7
- upper Limit
- 29.9
- value
- 7.0
- group Id
- OG002
- lower Limit
- 1.7
- upper Limit
- 30.0
- value
- 7.0
- denom Units Selected
- Number of Surgeries
- denoms
- counts
- group Id
- OG000
- value
- 10
- group Id
- OG001
- value
- 16
- group Id
- OG002
- value
- 26
- units
- Participants
- counts
- group Id
- OG000
- value
- 10
- group Id
- OG001
- value
- 17
- group Id
- OG002
- value
- 27
- units
- Number of Surgeries
- description
- Thirty participants who underwent surgery (31 surgeries) were determined to have neuropathic pain (NP). Four participants received only opioids for NP and 26 participants (for 27 surgeries) were treated with NP specific medications including gabapentin, tricyclic antidepressant, methadone. One participant had 2 different surgical procedures and was analyzed both in the limb sparing group and in the amputation group.
- dispersion Type
- Full Range
- groups
- description
- Participants had metastatic disease at diagnosis.
- id
- OG000
- title
- Amputation Group
- description
- Participants had localized disease at diagnosis. One participant had 2 surgeries.
- id
- OG001
- title
- Limb Sparing Group
- description
- Participants enrolled on the study who met the criteria for evaluation of neuropathic pain.
- id
- OG002
- title
- Entire Study Group
- param Type
- MEDIAN
- population Description
- All participants who met the criteria, had surgery, experienced neuropathic pain and were treated with NP medication.
- reporting Status
- POSTED
- time Frame
- From surgery until resolution of NP symptoms, up to 6 months
- title
- Median Duration of Neuropathic Pain Medication
- type
- OTHER_PRE_SPECIFIED
- type Units Analyzed
- Number of Surgeries
- unit Of Measure
- Weeks
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice